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Long-term epidemiological data reveal multi-annual ﬂuctuations in the incidence of dengue fever and
dengue haemorrhagic fever, as well as complex cyclical behaviour in the dynamics of the four serotypes of
the dengue virus. It has previously been proposed that these patterns are due to the phenomenon of the
so-called antibody-dependent enhancement (ADE) among dengue serotypes, whereby viral replication is
increased during secondary infection with a heterologous serotype; however, recent studies have implied
that this positive reinforcement cannot account for the temporal patterns of dengue and that some form of
cross-immunity or external forcing is necessary. Here, we show that ADE alone can produce the observed
periodicities and desynchronized oscillations of individual serotypes if its effects are decomposed into its
two possible manifestations: enhancement of susceptibility to secondary infections and increased
transmissibility from individuals suffering from secondary infections. This decomposition not only lowers
the level of enhancement necessary for realistic disease patterns but also reduces the risk of stochastic
extinction. Furthermore, our analyses reveal a time-lagged correlation between serotype dynamics and
disease incidence rates, which could have important implications for understanding the irregular pattern of
dengue epidemics.
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1. INTRODUCTION
Dengue is caused by infection with any one of the four
closely related virus serotypes DEN-1, DEN-2, DEN-3
and DEN-4 (Calisher et al. 1989), and transmitted to
humans primarily by the Aedes aegypti mosquito vector. Its
emergence and geographical spread are of major global
concern and it has seen a 30-fold increase in incidence
during the last 50 years. The virus currently affects over 50
million people annually in the tropical and subtropical
regions of the world and causes tens of thousands of
deaths (Gubler 2002; WHO 2008). Clinical manifesta-
tions of dengue can include dengue fever (DF) and the
more severe dengue shock syndrome and dengue haemor-
rhagic fever (DHF), a life-threatening illness with case
fatality rates up to 20 per cent in the absence of treatment
(which can be reduced to less than 1 per cent with proper
medical management).
Despite recent advances (Edelman 2007), there are
currently no licensed vaccines or effective antiviral drugs
available against the disease. One of the key problems in
developing a vaccine is that pre-existing antibodies to
a particular serotype can exacerbate an infection of a
heterologous serotype. This effect is hypothesized to be
due to the action of antibody-dependent enhancement, or
ADE, whereby cross-reactive antibodies elicited by a
previously encountered serotype bind to the newly
infecting heterologous serotype, but fail to neutralize it
(Halstead 1979). The virus–antibody complex engages Fc
receptors on the surface of cells such as macrophages and
dendritic cells (Takada & Kawaoka 2003), enabling the
virustoenterthecellmoreeasilyforreplication(Rothman&
Ennis 1999; Boonnak et al.2 0 0 8 ). Animal studies indicate
that the ADE process results in higher viral burdens
in vivo, which is likely to explain the epidemiological
association of severe disease with secondary infection by a
heterologous serotype (Burke et al. 1988; Thein et al.
1997; Vaughn et al. 2000; Goncalvez et al. 2007) and also
the association of severe disease in infants with passively
acquired antibody (Kliks et al. 1988; Chau et al. 2008).
The temporal epidemiological pattern of dengue is
characterized by multi-annual ﬂuctuations in DF or DHF
incidence and also cyclical oscillations of the individual
serotypes whereby the dominant type is sequentially
replaced over time (Nisalak et al. 2003); it is unclear,
however, whether and how these two features relate to one
another. Various mathematical models have been pro-
posed to illuminate these intriguing dynamics and to
uncover the driving forces behind them. The consequences
of the effect of ADE on the transmission dynamics of
dengue were studied by Ferguson et al. (1999), and it was
shown that ADE could promote the coexistence of strains
and lead to nonlinear dynamics. Cummings et al. (2005)
further demonstrated that ADE-driven dynamics can
provide a good qualitative approximation to the chaotic
desynchronization of strains as commonly observed within
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etal.2005),althoughtheselectiveadvantageofADEmaybe
capped by threats to persistence arising from increasingly
high amplitude oscillations. However, it has since been
argued that either the period of oscillations or the
desynchronization between serotypes generated by ADE
alone is not in good agreement with those observed among
reported time series of DHF cases, and that some form
of cross-protective immunity (Wearing & Rohani 2006;
Nagao & Koelle2008) or seasonal forcing(e.g. Adams et al.
2006) is necessarytoexplainthe observedepidemic periods
and disease patterns.
Here, we present the results of an epidemiological
model for dengue transmission, which employs two
parameters to represent the effects of ADE. In addition
to a parameter describing the enhancement of trans-
mission during secondary infection through increased
viraemia, we include the possibility of enhanced suscep-
tibility to heterologous infections among individuals
who have experienced primary infections due to the
existence of non-neutralizing cross-reactive antibodies.
We show that by including both facets explicitly, both the
observed temporal patterns of DF outbreaks and serotype
dynamics can robustly be reproduced without the need for
extrinsic factors such as seasonal variation or stochasticity.
The model further allows us to investigate the relationship
between the epidemic pattern of dengue and the dynamics
of the co-circulating serotypes. Analyses of time series
produced byour model suggest that overall incidence rates
and relative serotype prevalence, and especially their
respective rates of change, are intrinsically linked.
2. MATERIAL AND METHODS
(a) Mathematical model
We use a simple mathematical model to investigate the
transmission dynamics offour co-circulating dengue serotypes
within the population, similar to the one analysed by
Cummings et al.( 2 0 0 5 ) . We assume that recovery from an
infection with any one serotype provides permanent immunity
againstthisparticularserotype,butcanleadtoanenhancement
of other serotypes upon secondary infection after which
individuals acquire complete immunity against all four
serotypes. (The last assumption is based on the rarity of third
or fourth dengue infections; e.g. Gibbons et al.2 0 0 7 .) With
these assumptions, we divide the population into the following
classes: s denotes the fraction of the population that has not yet
been infected with any of the serotypes and is thus totally
susceptible; yi is the proportion infectious with a primary
infection with serotype i, ri is the proportion recovered from
primaryinfectionwithserotypei;yijistheproportioninfectious
with serotype j, having already recovered from infection with
serotype i;a n d ,ﬁ n a l l y ,r is the proportion of completely
immune (those who have recovered after being exposed to two
serotypes). The model equations are given as follows:
ds=dt ZmKs
X 4
kZ1
lkKms;
dyi=dt ZsliKðsCmÞyi;
dri=dt ZsyiKri mC
P
jsi gijlj
  
;
dyij=dt ZrigijljKðsCmÞyij; isj;
dr=dt Zs
X 4
iZ1
X
jsi
yijKmr:
The host population size is assumed to be constant with
1/m (Z70 years) being the average host life expectancy and
1/s (Z3.65 days) is the duration of infectiousness. As dengue
infections lasts less than a week (Kuno 1997), the incidence of
multiple simultaneous infections is assumed to be negligible.
Within this framework, the force of infection of serotype i, li,
is given by
li Zbi yi C
X
jsi
fjiyji
 !
;
where bi (Z400 per year) is the transmission coefﬁcient of
serotype i. The effects of ADE are represented by two
parameters that describe (i) the enhancement of suscepti-
bility to secondary infection, gijR1, and (ii) the increase in
transmissibility during secondary infection, fijR1.
The model behaviour can then be analysed by varying the
respective degrees of enhancement while keeping all other
parameters constant.
(b) Cross-correlation
To investigate a possible effect of the serotype dynamics on
disease prevalence within the population, we used a time-
dependent Shannon index of biodiversity
HðtÞ ZK
X
iZ1.4
piðtÞlogðpiðtÞÞ;
where pi(t) is the relative frequency of serotype i at time t, and
calculated the cross-correlation between the two time series
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Figure 1. Dengue epidemiology in South Viet Nam. (a) The
total annual number of dengue cases (blue bars) over
the period 1994–2007 shows the characteristic ﬂuctuation
in disease incidence, whereas the relative serotype prevalence
(1996–2007) clearly demonstrates the sequential replace-
ments of dominant types (dark blue line, DEN-1; red line,
DEN-2; yellow line, DEN-3; green line, DEN-4). (b)M o n t h l y
data of hospitalized dengue patients reveal a strong seasonal
component in total disease burden (blue bars), which is not
reﬂected in the relative frequency of the individual serotypes
(dark blue line, DEN-1; red line, DEN-2; yellow line, DEN-3;
green line, DEN-4).
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P
i; j yiðtÞCyijðtÞ
  
as follows:
rðDÞ ZðP5HÞðDÞ Z
P
tZ1.nðPtKmPÞðHtCDKmHÞ
sPsH
;
where mP and mH are the means, and sP and sH are the
standard deviations, of time-series P and H, respectively; n is
the number of data points.
(c) Data
Data on yearly patterns of disease incidence, monthly
patterns of dengue hospitalization and relative serotype
abundance in southern Viet Nam were kindly provided by
the dengue surveillance programme at the Institute Pasteur,
Ho Chi Minh City.
3. RESULTS
(a) Dengue epidemiology in southern Viet Nam
As in most countries in South East Asia, dengue is highly
endemic in Viet Nam, particularly in the tropical southern
regions of the country. Figure 1 shows the epidemiological
data of total disease incidence and relative serotype
prevalence for South Viet Nam from 1994 to 2007
(serological data were not available for the years 1994
and 1995), together with a more detailed temporal record
of children hospitalized with dengue at monthly time
intervals for the period 2004–2007. Figure 1a clearly
demonstrates the two key epidemiological features of
dengue: ﬁrst, the total incidence rates of DF/DHF show
marked variations over the years, with no indication of a
trend towards either reduced or increased disease burden
within this region. Second, the serotype dynamics display
the characteristic ﬂuctuations of single-type dominance
over time. Interestingly, despite the period covered by the
data in ﬁgure 1a being too short for a meaningful analysis of
the inter-epidemic period, it is obvious that it is likely to be
longer than the 3-year cycles often reported to underlie
dengue incidence rates in Thailand.
Figure 1b offers a more detailed picture of dengue
epidemiology within this region over a 4-year period,
revealing the strong seasonal component in dengue
transmission, which peaks between July and October
before dropping to very low levels over the drier winter
months. Notably, though, there is no pronounced com-
ponent of seasonal forcing in the longitudinal behaviour of
the individual serotypes. We therefore do not take into
account seasonal or stochastic variation in dengue trans-
mission, but investigate whether immune interaction
through ADE and cross-immunity can cause the cyclical
behaviour in disease incidence and serotype prevalence.
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Figure 2. Model output showing the proportion of the population infected over time under changes of the degrees of
enhancement. Each colour represents one of the four dengue serotypes.As the degree of enhancement increases (transmissibility
enhancement from left to right and susceptibility enhancement from top to bottom), the system exhibits a rich catalogue of
dynamical behaviours, from stable endemic equilibrium (gZ1, 4Z1) to synchronized oscillations (e.g. gZ1, 4Z1.9) and
desynchronized and chaotic ﬂuctuations with increased inter-epidemic periods (e.g. gZ1.8, 4Z1.9). The inter-epidemic
periods, p, also increase as the level of enhancement increases ((a) pZinf, (b) pZ4y,( c) pZ5y,( d) pZ4y,( e) pZ3y,(f ) pZ5y,
(g) pZ3y,( h) pZ4y and (i) pZ8y). Parameter values: (a) 4Z1, gZ1; (b) 4Z1.9, gZ1; (c) 4Z2.4, gZ1; (d) 4Z1, gZ2;
(e) 4Z1.9, gZ1.8; ( f ) 4Z2.4, gZ1.7; (g) 4Z1, gZ2.4; (h) 4Z1.9, gZ2.4; and (i) 4Z2.4, gZ2.4. Other parameter values:
bZ400, sZ100 and mZ1/70.
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To compare the relative impact of ADE on the trans-
mission dynamics of dengue and its four serotypes, we
used a simple compartmental model and performed a
series of simulations varying the two key model para-
meters: the enhancement of susceptibility to secondary
infection by a heterologous serotype, g, and the increased
transmissibility during secondary infection due to elevated
viral load, f (see §2 for full model description). Figure 2
shows the various time series tracing the level of
prevalence of the four serotypes within the population
over time in response to changes in g and f. The system
readily exhibits an abundance of different dynamical
behaviours. For small degrees of enhancement (f,g!1.2),
thesystemapproachesasteady-stateequilibrium(ﬁgure2a)
that is replaced by synchronized oscillations as the level of
enhancement increases. Further increase in g or f
desynchronizes the serotypes, resulting in out-of-phase
oscillations of increasing amplitude and periods. As the
effects of ADE amplify, we observe prolonged episodes of
very low disease prevalence with intermittent epidemic
outbreaks (ﬁgure 2i).
Of particular interest here is the region of chaotic
oscillations that most closely resemble the observed
temporal pattern of DF/DHF. Within this region, we
ﬁnd the characteristic multi-annual cycles (pw3–5 year)
in disease prevalence (see the electronic supplementary
material for the according periodograms) and, impor-
tantly, the sequential replacement of prevailing serotypes.
This behaviour is exempliﬁedin ﬁgure 3, which contrasts a
typical output of our model with a previously published
time record of dengue cases in Thailand (Nisalak et al.
2003). The ﬁgure shows a good qualitative agreement
between the data and model output in both overall
serotype dynamics and disease incidence.
We then analysed the model dynamics within the
parameter space of enhancement with respect to syn-
chrony between individual serotypes (ﬁgure 4a), serotype
replacement (ﬁgure 4b), inter-epidemic period (ﬁgure 4c)
and serotype persistence (ﬁgure 4d). From the time series
shown in ﬁgure 2, it is clear that the desynchroniza-
tion of serotypes leads to chaotic ﬂuctuations and the
characteristic replacements of the dominant types over
time. Studying the synchronization patterns within the
(f,g)-parameter plane by measuring the divergence
between various pairs of serotypes over time, we found
that desynchronization and hence chaotic oscillations
typify a signiﬁcant portion of the parameter region
(ﬁgure 4a). Using a measure for single-type dominance
similar to the one introduced by Recker et al. (2007),w e
also found that sequential serotype replacement where
individual serotypes are temporarily dominant charac-
terize most of the (f,g)-parameter space (ﬁgure 4b). This
conﬁrms that desynchronized ﬂuctuations in serotype
prevalence are not an artefact of a particular combination
of parameter values, but rather the principal model
behaviour under the action of ADE alone. Importantly,
these oscillations arise even at relatively small values of f
and g, and for realistic values of the basic reproductive
number, R0; that is, we do not require biologically
unreasonable high levels of enhancement (either in
transmissibility or susceptibility) to produce a realistic
epidemiological and serological pattern of dengue.
The reduction in the degree of enhancement necessary
for desynchronized oscillations achieved by the decom-
position of the effects of ADE has two important
implications for the system’s dynamical behaviour. First,
it allows for greater ﬂexibility in terms of inter-epidemic
periodswitha signiﬁcant proportion ofthe(f,g)-parameter
space yielding realistic 3–5 year epidemic cycles in disease
incidence(ﬁgure4c).Second,thereductioninenhancement
also lowers the threat of stochastic extinction due to large
amplitude oscillations (as shown in ﬁgure 4d) as the
proportion of time a particular serotype persists above a
given threshold level (we chose a threshold of 1E-8, in line
with Cummings et al. 2005).
(c) Relationship between serotype and
infection dynamics
We next investigated a possible association between
disease prevalence and serotype dynamics by measuring
diversity H(t) and total prevalence P(t) over a 50-year
period. Figure 5a shows a typical time course of relative
serotype frequency generated by our model, with the
according time series for disease prevalence, P, shown in
ﬁgure 5b. From ﬁgure 5b, we can identify the presence of a
time-lagged correlation between infection prevalence and
diversity, in that the ﬂuctuations in prevalence appear to
trail the ﬂuctuations in diversity. This time-delayed
correlation is even more pronounced between the time
courses of the rates of change in Pand H (dP/dt and dH/dt,
respectively), as shown in ﬁgure 5c. We conﬁrmed these
ﬁndings by computing the cross-correlations P5H and
dP/dt5dH/dt as a function of a lag between the two series
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Figure 3. Qualitative comparison between model output and
epidemiological data. (a) Data showing long-term record of
total disease incidence (blue bars) and relative serotype
prevalence in Thailand, taken from Nisalak et al. (2003) (dark
blue line, DEN-1; red line, DEN-2; yellow line, DEN-3;
green line, DEN-4). (b) Typical model outcome for a
moderate degree of ADE (gZ2.1, fZ1.8) showing desyn-
chronized oscillations in serotype prevalence and chaotic
ﬂuctuations in total disease prevalence (blue bars, arbitrary
units; green line, serotype1; yellow line, serotype2; dark blue
line, serotype3; red line, serotype4). Other parameter values:
bZ400, sZ100 and mZ1/70.
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Proc. R. Soc. B (2009)(see §2). The graph in ﬁgure 5d clearly demonstrates the
three principal ﬁndings: (i) there is a positive correlation
between the level of serotype diversity and infection
prevalence that is maximized at time-lag DP,( ii) the rate
of change in diversity correlates inversely with the rate of
change in disease prevalence, and (iii) the rate of change
in diversity is positively correlated with prevalence at lag
DdP. (This behaviour is also robust to changes in f and g,
and can be found across a vast region of the enhancement
spectrum; see the electronic supplementary material.)
Taken together, these results strongly suggest an intricate
interplay between the dynamics of individual serotypes
and overall disease pattern of dengue where an increase in
serotype diversity causes a subsequent increase in disease
prevalence, which itself can cause a reduction in the
number of circulating types.
4. DISCUSSION
The limited amount of data available on the dynamics of
co-circulating dengue serotypes suggest that they are
complex, containing periods of synchronization between
certain serotypes and desynchronization among others.
Simple models of dengue transmission incorporating ADE
havedemonstratedthatthisbehaviourisanaturalfeatureof
suchasystem(Fergusonetal.1999;Cummingsetal.2005;
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Figure 4. Analysis of the parameter space of enhancement. The (f,g)-parameter space can be qualiﬁed with respect to
(a) synchronization patterns between two individual serotypes, (b) single-serotype prevalence, (c) major inter-epidemic period,
and (d) serotype persistence. (a) The four synchronization patterns between serotypes (i) 1 and 2, (ii) 1 and 3, (iii) 2 and 3,
and (iv) 3 and 4 reveal that the majority of the parameter space is occupied by desynchronized (blue) behaviour. Complete
synchronization (red) indicates that after some initial transient, the time series of the two serotypes coincide and stay locked for
the rest of the time interval; partial synchronization (green) is deﬁned as a regime in which the time series are not fully
synchronized, but throughout their 1000-year integration period have intervals of more than 100 years of synchronized
behaviour. (b) Within the regime of desynchronized oscillation, we also ﬁnd the system’s behaviour being characterized by
single-serotype replacement and dominance, where 0 indicates that at least two types are simultaneously dominant. (c)A s
the respective degrees of enhancement increase, we ﬁnd the periods between epidemic outbreaks becoming longer, with a
typical 3–5 year cycle occupying a large part of the parameter space and longer cycles (5–15 years) occurring towards the
higher end of the enhancement spectrum. (d) The proportion of time a particular serotype persists above a persistence-
threatening threshold level of 10
K8 drops sharply as the level of enhancement increases, but remains high throughout a
large region of the parameter space occupied by desynchronized, chaotic oscillations. Other parameter values: bZ400, sZ100
and mZ1/70.
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Proc. R. Soc. B (2009)Schwartzetal.2005),providedthatheterologousimmunity
is established upon secondary infection. However, it has
recently been posited that ADE alone cannot account for
the observed patterns, and that some form of cross-
immunity after primary infection, in conjunction with
other extrinsic factors, must be invoked to generate the
appropriate periods and synchronization proﬁles (Adams
etal.2006).Here,wehaveshownthatthislimitationcanbe
overcome by decomposing the effects of ADE on the
populationdynamicsofdengueintotwoindependentforms
of enhancement: susceptibility and transmission. A wide
range of dynamical regimes results from the disjunction
between these two parameters, which easily accommodate
the asynchrony of different serotypes and inter-epidemic
periods of 3–5 years that the data evince. Furthermore,
decomposing the effects of ADE signiﬁcantly lowers
the levels of enhancement necessary for obtaining realistic
disease patterns. This has the added beneﬁt of reduc-
ing the system’s propensity for exhibiting the high
amplitude oscillations, which in turn lowers the risk of
stochastic extinction during the low-prevalence, inter-
epidemic periods.
While our results suggest that ADE alone can give rise
to observed patterns of serotype abundance through time,
they do not rule out immunological cross-protection after
primary infection as a contributing phenomenon. Indeed,
immunological cross-protection through shared epitopes
among four serotypes can give rise to periods of
asynchrony (Recker et al. 2007), but not as reliably as
through the action of ADE. Furthermore, the inclusion of
a period of serotype-transcending immunity following
primary infection can also cause desynchronized oscil-
lations, even in the absence of ADE (Aguiar et al. 2008).
However, in this case, the resulting periods in serotype
prevalence and disease incidence are strongly coupled to
the period of cross-immunity, a limitation that can easily
be overcome by the inclusion of ADE. Another putative
mechanism by which the dynamics of dengue can be
explained has recently been suggested by Nagao & Koelle
(2008); they conclude that a transient period of clinical
cross-protection during which the hosts may gain
immunity through heterologous infections without devel-
oping disease (together with seasonal variation in trans-
mission) can account for observed epidemiological
patterns, particularly the apparent shift towards longer
periods in DHF incidence and in its age distribution.
There is, however, no strong evidence as yet in favour of
this mechanism.
There are a number of methods of discriminating
between these various hypotheses. Certainly, further
experimental studies on the effects of ADE are necessary
to conﬁrm its role of enhancing susceptibility and
transmissibility within individuals suffering from severe
disease during secondary infections. Its role in DHF has
also yet to be clariﬁed, although it is clear that excess
mortality alone cannot account for observed dengue
patterns (Wearing & Rohani 2006), but may play a role
in the separation of serotypes (Kawaguchi et al. 2003).
The extent of cross-protection conferred by primary
infection can also be determined by experimental studies,
and its role in the population dynamics of dengue may
possibly be assessed by comparing patterns of dengue with
other strain-structured pathogens where immunological
cross-protection has been demonstrated. Similarly, the
contribution of environmental factors will be better
established as data emerge on patterns in areas of differing
intensities and seasonalities of transmission. Spatial
models and phylodynamic tools (as used in Adams et al.
2006) will play a critical role in connecting these processes
to the patterns observed.
Oneavenuewehavenotyet exploredisthe possibilityof
asymmetries in the levels of enhancement (or cross-
protection) between the four serotypes. For example,
there is evidence that DENV-2 is more often associated
with severe secondary infection, which suggests that it
requires heterologous priming to cause severe disease
(Sangkawibha et al. 1984; Anantapreecha et al. 2005).
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Figure 5. Cross-correlation analysis between serotype
diversity and disease prevalence. (a) Time series of the
relative frequency of the four dengue serotypes (red line,
DEN-1; green line, DEN-2; yellow line, DEN-3; dark blue
line, DEN-4) with (b) total disease prevalence (P, dark blue)
and corresponding serotype diversity (H, red line); (c) the
rates of change in prevalence and diversity, dP/dt and dH/dt,
respectively. (d) The cross-correlation, r(D), between preva-
lence and diversity, P!H (black line), over a 100-year period
revealsabimodaldistributionwithtwosigniﬁcantpeaksattime
lags DP and DKP and a ‘dip’ at lag DZ0. This dip can be
explained by the negative correlation at this point between the
rates of change in prevalence and diversity, dP/dt!dH/dt
(red line). The bimodal shape of the cross-correlation
between the rates of change also reveals the negative feedback
between prevalence and diversity. Parameter values: gZ2.1,
fZ1.8, bZ400, sZ100 and mZ1/70.
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terms of the sequence of infection, as shown by Endy et al.
(2004). However, the inherent difﬁculty in determining
infection histories from patient sera, due to high immuno-
logical cross-reactivity, prevents the construction of a
coherent picture of serotype–serotype (immune)
interaction. Future longitudinal cohort studies should
help to illuminate the antigenic and genetic relationships
between the circulating dengue serotypes. These will also
helptoelucidatethepossiblecorrelationbetweenincidence
of disease and serotype diversity identiﬁed by our model.
Finally, the enhancement of transmission as opposed to
an increase in susceptibility may well be attributed to a
different mechanism to ADE. A recent study shows DHF
patients exhibit both a higher viral load and a slower rate
of viral clearance in comparison with DF patients
(Wang et al. 2006). For the latter, viral loads drop to
undetectable levels by the ﬁrst day of defervescence, but
they remain at high levels in DHF patients. This difference
in the rate of loss of viraemia is better explained by
interference in the development of the appropriate
immune response either byoriginal antigenic sin or altered
peptide ligand antagonism. If so, the two parameters in
our model could represent two different positive
interactions between serotypes, rather than two aspects
of ADE alone. Whichever the biological basis, the
decomposition into effects on susceptibility and trans-
missionaffordsaparsimoniousexplanationfor theobserved
variety in the epidemiological behaviour of dengue.
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